Intensity Therapeutics(INTS) - 2025 FY - Earnings Call Transcript

Financial Data and Key Metrics Changes - A majority of votes were cast in favor of the approval of the reverse stock split proposal and the adjournment proposal, indicating shareholder support for these strategic decisions [9][10]. Business Line Data and Key Metrics Changes - No specific business line data or key metrics were discussed during the meeting [0]. Market Data and Key Metrics Changes - No specific market data or key metrics were provided during the meeting [0]. Company Strategy and Development Direction and Industry Competition - The company plans to implement a reverse stock split by a ratio of not less than one for five and not more than one for thirty, with the exact ratio to be determined by the Board of Directors [7]. Management's Comments on Operating Environment and Future Outlook - Management indicated that the decision regarding the reverse stock split will be made at a time deemed necessary by the Board of Directors, emphasizing the importance of timing in this strategic move [12]. Other Important Information - The meeting was conducted virtually to enhance accessibility for shareholders, and a quorum was established with 46.13% of the outstanding voting stock present [6]. Q&A Session All Questions and Answers Question: When would you decide to do the reverse split? And when would you decide what number of shares to reduce it to? - The decision will be determined by the Board of Directors in their sole discretion, with the implementation expected to occur before the deadline [12]. Question: Do we have any further questions? - No further questions were received, and the Q&A portion of the meeting was closed [13].